InvestSMART

ResMed Inc. (ASX:RMD)

ALERT: Price-sensitive ASX Announcement for RMD
Current share price for RMD : $28.750 -7.65 (-21.02%)+
Announcement
Release
30 Jan 2026 8:26AM
Price at Release
$36.400
Full Release
download
Summary
ResMed Inc. announced its financial results for the second quarter of fiscal year 2026, ending December 31, 2025. The company reported a revenue of $1.422 billion, a 11% increase from the previous year's $1.282 billion. This growth was driven by strong sales in the U.S., Canada, and Latin America, with devices and masks contributing significantly to this performance. The company's non-GAAP gross profit margin improved to 62.3%, compared to 59.2% in the same quarter last year. ResMed also reported a notable increase in net income, reaching $392.6 million, up from $344.6 million in the previous year, and diluted earnings per share grew to $2.68. The financial results highlight ResMed's solid market presence and efficient operational execution despite global economic challenges.
Key Points
  • Revenue increased by 11% to $1.422 billion.
  • Non-GAAP gross profit margin improved to 62.3%.
  • Net income rose to $392.6 million, an increase from $344.6 million.
  • Diluted earnings per share increased to $2.68.
  • Strong sales performance in U.S., Canada, and Latin America.
  • Growth driven by devices and masks sales.
  • Operational efficiency improved despite global challenges.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.